Clinical Trial Update: MLC1501 Study Assessing Efficacy in STROke Recovery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update for MLC1501 evaluating efficacy in stroke recovery; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Stroke Sequelae

Drugs mentioned

• MLC1501

Snippet

Sponsor: Moleac Pte Ltd. | Conditions: Stroke, Stroke, Ischemic | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING